165 related articles for article (PubMed ID: 8209384)
1. Acute behavioral toxicity of pyridostigmine or soman in primates.
Blick DW; Murphy MR; Brown GC; Yochmowitz MG; Fanton JW; Hartgraves SL
Toxicol Appl Pharmacol; 1994 Jun; 126(2):311-8. PubMed ID: 8209384
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of alpha 2-adrenergic receptor stimulation in reducing the central toxicity following cholinesterase inhibition.
Buccafusco JJ; Li W
Res Commun Chem Pathol Pharmacol; 1992 Jan; 75(1):85-98. PubMed ID: 1352646
[TBL] [Abstract][Full Text] [Related]
3. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
[TBL] [Abstract][Full Text] [Related]
4. Behavioral toxicity of anticholinesterases in primates: chronic pyridostigmine and soman interactions.
Blick DW; Kerenyi SZ; Miller S; Murphy MR; Brown GC; Hartgraves SL
Pharmacol Biochem Behav; 1991 Mar; 38(3):527-32. PubMed ID: 2068189
[TBL] [Abstract][Full Text] [Related]
5. Protection by pyridostigmine bromide of marmoset hemi-diaphragm acetylcholinesterase activity after soman exposure.
Haigh JR; Adler M; Apland JP; Deshpande SS; Barham CB; Desmond P; Koplovitz I; Lenz DE; Gordon RK
Chem Biol Interact; 2010 Sep; 187(1-3):416-20. PubMed ID: 20144889
[TBL] [Abstract][Full Text] [Related]
6. Behavioral toxicity of anticholinesterases in primates: effects of daily repeated soman exposure.
Blick DW; Weathersby FR; Brown GC; Murphy MR
Pharmacol Biochem Behav; 1994 Jul; 48(3):643-9. PubMed ID: 7938117
[TBL] [Abstract][Full Text] [Related]
7. Primate performance decrements following acute soman exposure: failure of chemical countermeasures.
Blick DW; Murphy MR; Brown GC; Hartgraves SL
Pharmacol Biochem Behav; 1994 Nov; 49(3):503-10. PubMed ID: 7862701
[TBL] [Abstract][Full Text] [Related]
8. Toxic interactions between repeated soman and chronic pyridostigmine in rodents.
Kerenyi SZ; Murphy MR; Hartgraves SL
Pharmacol Biochem Behav; 1990 Oct; 37(2):267-71. PubMed ID: 2080189
[TBL] [Abstract][Full Text] [Related]
9. Time Course, Behavioral Safety, and Protective Efficacy of Centrally Active Reversible Acetylcholinesterase Inhibitors in Cynomolgus Macaques.
Hamilton LR; Schachter SC; Myers TM
Neurochem Res; 2017 Jul; 42(7):1962-1971. PubMed ID: 27900576
[TBL] [Abstract][Full Text] [Related]
10. Effects of daily stress or repeated paraoxon exposures on subacute pyridostigmine toxicity in rats.
Shaikh J; Karanth S; Chakraborty D; Pruett S; Pope CN
Arch Toxicol; 2003 Oct; 77(10):576-83. PubMed ID: 14574445
[TBL] [Abstract][Full Text] [Related]
11. Effective countermeasure against poisoning by organophosphorus insecticides and nerve agents.
Albuquerque EX; Pereira EF; Aracava Y; Fawcett WP; Oliveira M; Randall WR; Hamilton TA; Kan RK; Romano JA; Adler M
Proc Natl Acad Sci U S A; 2006 Aug; 103(35):13220-5. PubMed ID: 16914529
[TBL] [Abstract][Full Text] [Related]
12. Behavioral toxicity of anticholinesterases in primates: chronic physostigmine and soman interactions.
Blick DW; Miller SA; Brown GC; Murphy MR
Pharmacol Biochem Behav; 1993 Jul; 45(3):677-83. PubMed ID: 8332626
[TBL] [Abstract][Full Text] [Related]
13. Effect of carboxylesterase inhibition on carbamate protection against soman toxicity.
Maxwell DM; Brecht KM; Lenz DE; O'Neill BL
J Pharmacol Exp Ther; 1988 Sep; 246(3):986-91. PubMed ID: 3418520
[TBL] [Abstract][Full Text] [Related]
14. Diazepam as a treatment for nerve agent poisoning in primates.
Murphy MR; Blick DW; Dunn MA; Fanton JW; Hartgraves SL
Aviat Space Environ Med; 1993 Feb; 64(2):110-5. PubMed ID: 8431183
[TBL] [Abstract][Full Text] [Related]
15. The protection of primates against soman poisoning by pretreatment with pyridostigmine.
Dirnhuber P; French MC; Green DM; Leadbeater L; Stratton JA
J Pharm Pharmacol; 1979 May; 31(5):295-9. PubMed ID: 37298
[TBL] [Abstract][Full Text] [Related]
16. Cholinesterases as scavengers for organophosphorus compounds: protection of primate performance against soman toxicity.
Doctor BP; Blick DW; Caranto G; Castro CA; Gentry MK; Larrison R; Maxwell DM; Murphy MR; Schutz M; Waibel K
Chem Biol Interact; 1993 Jun; 87(1-3):285-93. PubMed ID: 8343986
[TBL] [Abstract][Full Text] [Related]
17. Identical kinetics of human erythrocyte and muscle acetylcholinesterase with respect to carbamate pre-treatment, residual activity upon soman challenge and spontaneous reactivation after withdrawal of the inhibitors.
Herkert NM; Eckert S; Eyer P; Bumm R; Weber G; Thiermann H; Worek F
Toxicology; 2008 Apr; 246(2-3):188-92. PubMed ID: 18304715
[TBL] [Abstract][Full Text] [Related]
18. Protection of red blood cell acetylcholinesterase by oral huperzine A against ex vivo soman exposure: next generation prophylaxis and sequestering of acetylcholinesterase over butyrylcholinesterase.
Haigh JR; Johnston SR; Peppernay A; Mattern PJ; Garcia GE; Doctor BP; Gordon RK; Aisen PS
Chem Biol Interact; 2008 Sep; 175(1-3):380-6. PubMed ID: 18572153
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of oral pyridostigmine pretreatment and cholinolytic-oxime therapy against soman intoxication in nonhuman primates.
von Bredow JD; Adams NL; Groff WA; Vick JA
Fundam Appl Toxicol; 1991 Nov; 17(4):761-70. PubMed ID: 1778362
[TBL] [Abstract][Full Text] [Related]
20. In vitro kinetic interactions of pyridostigmine, physostigmine and soman with erythrocyte and muscle acetylcholinesterase from different species.
Herkert NM; Thiermann H; Worek F
Toxicol Lett; 2011 Sep; 206(1):41-6. PubMed ID: 21414391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]